Earlier this month, Agilent agreed to acquire Philadelphia based Proscia, a provider of digital pathology software for clinical and life-sciences customers, for $240M up front and up to $30M more
Co-Founder & CEO David West describes the deal and why Proscia believes Agilent can take the business to a new level, and discusses how AI is changing pathology.









.png)